MedTrace Logo

A Study in Healthy Men to Investigate Uptake and Distribution of Lu AF88434 in the Brain

NCT04538014 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2021-02-24

No results posted yet for this study

Summary

This study will investigate how much of Lu AF88434 will get into the blood and the brain in healthy men

Conditions

  • Healthy

Interventions

DRUG

Lu AF88434

Oral solution

DRUG

[11C]-Lu AF88434

\[11C\]-Lu AF88434, and a radioactive dose not exceeding 400 MBq at each PET examination, intravenous bolus injection

Sponsors & Collaborators

  • H. Lundbeck A/S

    lead INDUSTRY

Principal Investigators

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-24
Primary Completion
2020-10-21
Completion
2020-10-21

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04538014 on ClinicalTrials.gov